Drug Profile
Research programme: liver X receptor agonists - Organon
Alternative Names: ORG 235497Latest Information Update: 16 Nov 2009
Price :
$50
*
At a glance
- Originator Organon
- Class
- Mechanism of Action Liver X receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Nov 2009 No development reported - Preclinical for Undefined indication in USA (unspecified route)
- 12 Dec 2007 Preclinical trials in Undefined indication in USA (unspecified route)
- 19 Nov 2007 Organon has been acquired and merged into Schering-Plough